pamidronate has been researched along with Osteosclerosis in 9 studies
Osteosclerosis: An abnormal hardening or increased density of bone tissue.
| Excerpt | Relevance | Reference |
|---|---|---|
| "These results suggest that etidronate may 1) inhibit the entry of NBPs into cells related to inflammation and/or necrosis, 2) inhibit the binding of NBPs to bone hydroxyapatite, 3) at least partly eliminate (or substitute for) NBPs that have already accumulated within bones, and thus 4) if used as a substitution drug for NBPs, be effective at treating or preventing NBP-associated osteonecrosis of the jaw." | 3.76 | Inhibition of necrotic actions of nitrogen-containing bisphosphonates (NBPs) and their elimination from bone by etidronate (a non-NBP): a proposal for possible utilization of etidronate as a substitution drug for NBPs. ( Endo, Y; Funayama, H; Kawamura, H; Kumamoto, H; Kuroishi, T; Oizumi, T; Sasaki, K; Sugawara, S; Takahashi, H; Yamaguchi, K; Yamamoto, M; Yokoyama, M, 2010) |
| "Haematologic malignancies and solid tumors are often complicated by the bone tissue destruction." | 2.39 | [Pharmacologic therapy of bone tissue changes due to hematologic malignancies and bone metastasis]. ( Kiełbiński, M, 1994) |
| "Hepatitis C has recently been recognized as a secondary cause of osteosclerosis; a further example, the first outside of North America, is described." | 1.29 | Acquired osteosclerosis associated with intravenous drug use and hepatitis C infection. ( Depczynski, B; Diamond, T, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamada, H | 1 |
| Matsuo, A | 1 |
| Koizumi, T | 1 |
| Satomi, T | 1 |
| Chikazu, D | 1 |
| Whyte, MP | 1 |
| Madson, KL | 1 |
| Mumm, S | 1 |
| McAlister, WH | 1 |
| Novack, DV | 1 |
| Blair, JC | 1 |
| Helliwell, TR | 1 |
| Stolina, M | 1 |
| Abernethy, LJ | 1 |
| Shaw, NJ | 1 |
| Füeßl, HS | 1 |
| Otto, S | 1 |
| Schuler, K | 1 |
| Ihrler, S | 1 |
| Ehrenfeld, M | 1 |
| Mast, G | 1 |
| Oizumi, T | 1 |
| Funayama, H | 1 |
| Yamaguchi, K | 1 |
| Yokoyama, M | 1 |
| Takahashi, H | 1 |
| Yamamoto, M | 1 |
| Kuroishi, T | 1 |
| Kumamoto, H | 1 |
| Sasaki, K | 1 |
| Kawamura, H | 1 |
| Sugawara, S | 1 |
| Endo, Y | 1 |
| Treister, NS | 1 |
| Friedland, B | 1 |
| Woo, SB | 1 |
| Kaji, H | 1 |
| Naito, J | 1 |
| Sowa, H | 1 |
| Sugimoto, T | 1 |
| Chihara, K | 1 |
| Kiełbiński, M | 1 |
| Diamond, T | 1 |
| Depczynski, B | 1 |
2 reviews available for pamidronate and Osteosclerosis
| Article | Year |
|---|---|
Osteonecrosis or metastases of the jaw or both? Case report and review of the literature.
Topics: Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Dipho | 2010 |
[Pharmacologic therapy of bone tissue changes due to hematologic malignancies and bone metastasis].
Topics: Bone Neoplasms; Calcitonin; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Neoplasms; Osteo | 1994 |
7 other studies available for pamidronate and Osteosclerosis
| Article | Year |
|---|---|
A simple evaluation method for early detection of bisphosphonate-related osteonecrosis of the mandible using computed tomography.
Topics: Administration, Intravenous; Administration, Oral; Alendronate; Alveolar Process; Bisphosphonate-Ass | 2014 |
Rapid skeletal turnover in a radiographic mimic of osteopetrosis.
Topics: Bone Remodeling; Child; Diphosphonates; Humans; Male; Osteoporosis; Osteosclerosis; Pamidronate; Rad | 2014 |
[Zebra bones after bisphosphonate treatment].
Topics: Bone Density; Child; Diphosphonates; Drug Administration Schedule; Humans; Male; Osteoclasts; Osteog | 2015 |
Inhibition of necrotic actions of nitrogen-containing bisphosphonates (NBPs) and their elimination from bone by etidronate (a non-NBP): a proposal for possible utilization of etidronate as a substitution drug for NBPs.
Topics: Alendronate; Animals; Bone Density Conservation Agents; Bone Resorption; Diphosphonates; Ear, Extern | 2010 |
Use of cone-beam computerized tomography for evaluation of bisphosphonate-associated osteonecrosis of the jaws.
Topics: Adult; Aged; Alendronate; Bone Density Conservation Agents; Cone-Beam Computed Tomography; Diphospho | 2010 |
Serum soluble factors induce the proliferation, alkaline phosphatase activity and transforming growth factor-beta signal in osteoblastic cells in the patient with hepatitis C-associated osteosclerosis.
Topics: 3T3 Cells; Absorptiometry, Photon; Alkaline Phosphatase; Animals; Bone and Bones; Bone Development; | 2006 |
Acquired osteosclerosis associated with intravenous drug use and hepatitis C infection.
Topics: Adult; Bone Density; Bone Diseases; Diphosphonates; Femur; Hepatitis C; Humans; Lumbar Vertebrae; Ma | 1996 |